The effect of Inhaled Nicotine on Pulmonary Surfaces
吸入尼古丁对肺表面的影响
基本信息
- 批准号:10089471
- 负责人:
- 金额:$ 55.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAdverse effectsAffectAttenuatedBiochemicalBiophysicsBlood - brain barrier anatomyBlood CirculationBrainCardiovascular DiseasesCardiovascular systemCell CountCholineChronic BronchitisChronic Obstructive Airway DiseaseConeCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDataDehydrationDiseaseDisease ProgressionDown-RegulationEffectivenessElectronic cigaretteEndoplasmic ReticulumFailureFlushingFunctional disorderHealthHumanHydration statusImmunosuppressionImpairmentIn VitroInfectionInflammationInhalationIon Channel GatingIon TransportLeadLigandsLinkLiquid substanceLungLung diseasesMalignant neoplasm of lungMediatingMicroRNAsMicroscopyMicrospheresMucinsMucous body substanceNicotineOutcomePharmacologyPhenotypePhosphoric Monoester HydrolasesPolymersProductionPropertyPropylene GlycolsProtein DephosphorylationProteinsProteomePublic HealthResolutionRespiratory syncytial virusRheologyRiskRouteSignal TransductionSmokerSmokingSodium ChlorideSolidStructureSuggestionSurfaceSystemTechniquesTestingTobaccoViralVirusVirus DiseasesWaterabsorptionairway obstructionbasebronchial epitheliumelectronic cigarette userimmunosuppressedin vivomass spectrometermucus clearancenicotine exposurenicotine inhalationreceptorrespiratory infection virusrespiratory virusresponseretrograde transporttraffickingvegetable glycerinviscoelasticity
项目摘要
Nicotine is the pharmacologically active/addictive compound in tobacco. As such, the lung serves as an ideal
and efficient delivery route for nicotine absorption into the bloodstream where it can then cross the blood brain
barrier and induce psychotropic effects on the brain. Recently, with the advent of electronic cigarettes (E-
Cigs), people have begun inhaling purified nicotine in a liquid vehicle (typically vegetable glycerin/propylene
glycol). While the effects of nicotine on the brain and cardiovascular system are well known, the effects of
nicotine on the lung have been less studied. Mucus clearance is a major part of the lung's innate defense
system and represents the first point of contact of the body with inhaled nicotine. Perturbations in CFTR-
mediated ion transport, which is required for mucus hydration/clearance, or biochemical alterations to mucins
impair this system, leaving the lung more prone to mucus accumulation/plugging and viral infections, as
evidenced by cystic fibrosis and chronic bronchitis lung disease. Our preliminary data indicate that E-cig users
have a drastically altered mucus proteome which is suggestive of immunosuppression. In vitro, we found that
nicotine, acting through intracellular Ca2+ (i) dephosphorylated CFTR leading to CFTR inactivation and
internalization to the endoplasmic reticulum and (ii) altered mucin rheology by directly interacting with mucins.
Furthermore, our data also suggest that the normal ability of the airways to activate CFTR and secrete mucins
to generate an “airway flush” to remove inhaled viruses is impaired following nicotine exposure, which is
predicted to lead to a failure to resolve common viral infections such as respiratory syncytial virus. We
hypothesize therefore, that nicotine causes an immunosuppressed phenotype that leaves the lung
more prone to viral exacerbations. Specifically, we propose that (i) nicotine-induced Ca2+ signaling leads to
CFTR dephosphorylation and internalization to the endoplasmic reticulum (ii) altered mucus rheology and (iii) a
failure to efficiently resolve viral infections. We shall study this hypothesis with the following specific aims:
Aim 1. To test the hypothesis that nicotine, via increases in intracellular Ca2+, causes CFTR
dephosphorylation and retrograde transport of CFTR to the ER that leads to ASL dehydration.
Aim 2. To assess the impact of nicotine on mucin secretion, mucus/mucin biophysical and barrier
properties, including their integrity, polymeric structure, and maturation.
Aim 3. To determine the impact of inhaled nicotine on outcomes of respiratory virus infection in vivo.
尼古丁是烟草中具有药理活性/成瘾性的化合物,因此,肺是理想的选择。
尼古丁吸收到血液中的有效输送途径,然后可以穿过血脑
最近,随着电子烟(E-)的出现,对大脑产生了屏障和诱导精神作用。
香烟),人们已经开始吸入液体载体(通常是植物甘油/丙烯)中的纯化尼古丁
虽然尼古丁对大脑和心血管系统的影响众所周知,但尼古丁的影响
尼古丁对肺部的影响研究较少。 粘液清除是肺部先天防御的主要部分。
系统并代表身体与 CFTR- 中吸入尼古丁扰动的第一个接触点。
介导的离子运输,这是粘液水合/清除或粘蛋白生化改变所必需的
损害该系统,使肺部更容易出现粘液积聚/堵塞和病毒感染,例如
我们的初步数据表明,电子烟使用者患有囊性纤维化和慢性支气管炎肺部疾病。
在体外,我们发现粘液蛋白质组发生了显着改变,表明存在免疫抑制。
尼古丁,通过细胞内 Ca2+ 起作用 (i) 去磷酸化 CFTR 导致 CFTR 失活,
内质网内化和(ii)通过与粘蛋白直接相互作用而实现粘蛋白流变学。
此外,我们的数据还表明气道激活 CFTR 和分泌粘蛋白的正常能力
接触尼古丁后,产生“气道冲洗”以清除吸入病毒的能力会受到损害,这是
预计将导致无法解决呼吸道合胞病毒等常见病毒感染。
因此,尼古丁会导致免疫抑制表型离开肺部
具体来说,我们认为 (i) 尼古丁诱导的 Ca2+ 信号传导会导致病毒恶化。
CFTR 去磷酸化和内化至内质网 (ii) 粘液流变学和 (iii)
未能有效解决病毒感染问题,我们将通过以下具体目标来研究这一假设:
目标 1. 检验尼古丁通过增加细胞内 Ca2+ 导致 CFTR 的假设
CFTR 去磷酸化和逆行转运至 ER,导致 ASL 脱水。
目标 2. 评估尼古丁对粘蛋白分泌、粘液/粘蛋白生物物理和屏障的影响
特性,包括其完整性、聚合结构和成熟度。
目标 3. 确定吸入尼古丁对体内呼吸道病毒感染结果的影响。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tobacco exposure inhibits SPLUNC1-dependent antimicrobial activity.
烟草暴露会抑制 SPLUNC1 依赖性抗菌活性。
- DOI:10.1186/s12931-019-1066-2
- 发表时间:2019
- 期刊:
- 影响因子:5.8
- 作者:Moore,PatrickJ;Sesma,Juliana;Alexis,NeilE;Tarran,Robert
- 通讯作者:Tarran,Robert
A modified fluorescent sensor for reporting glucose concentration in the airway lumen.
- DOI:10.1371/journal.pone.0254248
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Bearham J;Krutrök N;Lindberg B;Woodall M;Astrand A;Taylor JD;Biggart M;Vasiljevs S;Tarran R;Baines DL
- 通讯作者:Baines DL
Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cellular Membrane Potential Are Predictors of E-Liquid Induced Cellular Toxicity.
- DOI:10.1093/ntr/ntaa177
- 发表时间:2020-12-15
- 期刊:
- 影响因子:0
- 作者:Correia-Álvarez E;Keating JE;Glish G;Tarran R;Sassano MF
- 通讯作者:Sassano MF
Loose ENDs: Electronic Nicotine Delivery Systems and the FDA's Recent Enforcement Policy.
松散的电子烟头:电子尼古丁输送系统和 FDA 的最新执法政策。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Ahmad,Saira;Sassano,MFlori;Tarran,Robert
- 通讯作者:Tarran,Robert
Mucins MUC5AC and MUC5B in the Airways: MUCing around Together.
- DOI:10.1164/rccm.202208-1459ed
- 发表时间:2022-11-01
- 期刊:
- 影响因子:24.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mehmet Kesimer其他文献
Mehmet Kesimer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mehmet Kesimer', 18)}}的其他基金
The effect of Inhaled Nicotine on Pulmonary Surfaces
吸入尼古丁对肺表面的影响
- 批准号:
10083514 - 财政年份:2020
- 资助金额:
$ 55.72万 - 项目类别:
The effect of Inhaled Nicotine on Pulmonary Surfaces
吸入尼古丁对肺表面的影响
- 批准号:
9234295 - 财政年份:2017
- 资助金额:
$ 55.72万 - 项目类别:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
COPD 中的气道粘液/粘蛋白组成和蛋白质组:SPIROMICS 辅助研究
- 批准号:
8521361 - 财政年份:2011
- 资助金额:
$ 55.72万 - 项目类别:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
COPD 中的气道粘液/粘蛋白组成和蛋白质组:SPIROMICS 辅助研究
- 批准号:
8215467 - 财政年份:2011
- 资助金额:
$ 55.72万 - 项目类别:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
COPD 中的气道粘液/粘蛋白组成和蛋白质组:SPIROMICS 辅助研究
- 批准号:
8323313 - 财政年份:2011
- 资助金额:
$ 55.72万 - 项目类别:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
COPD 中的气道粘液/粘蛋白组成和蛋白质组:SPIROMICS 辅助研究
- 批准号:
8688051 - 财政年份:2011
- 资助金额:
$ 55.72万 - 项目类别:
The role of mucin-protein interactions in the innate defense of the lung
粘蛋白-蛋白质相互作用在肺先天防御中的作用
- 批准号:
8656401 - 财政年份:2010
- 资助金额:
$ 55.72万 - 项目类别:
The role of mucin-protein interactions in the innate defense of the lung
粘蛋白-蛋白质相互作用在肺先天防御中的作用
- 批准号:
8116579 - 财政年份:2010
- 资助金额:
$ 55.72万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
- 批准号:
10638221 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin Device
使用皮肤喷雾装置治疗隐性营养不良性大疱性表皮松解症的 iPS 细胞疗法的安全性、耐受性和有效性研究
- 批准号:
10721324 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Vitiligo topical treatment applying a potent, highly selective MC1R agonist
使用强效、高选择性 MC1R 激动剂进行白癜风局部治疗
- 批准号:
10759768 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV
大麻和影响艾滋病毒血脑屏障功能的致病机制
- 批准号:
10683027 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别: